Cryoport, Inc. (CYRX)

NCM – Real vaqt narxi. Valyuta: USD

14.78

-0.17 (-1.14%)

Bozor ochiq: Aug 12, 2026, 1:05 PM EDT

15.05

+0.10 (0.67%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

11.08.2026

CryoPort (CYRX) Upgraded to Buy: Here's Why

CryoPort (CYRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

07.08.2026

Cryoport, Inc. (CYRX) Q2 2026 Earnings Call Transcript

07.08.2026

CryoPort Q2 Earnings Call Highlights

CryoPort NASDAQ: CYRX reported second-quarter 2026 revenue of $49 million and said it reached positive adjusted EBITDA from continuing operations, while reaffirming its full-year revenue outlook of $192 million to $196 million.

06.08.2026

CryoPort, Inc. (CYRX) Reports Q2 Loss, Beats Revenue Estimates

CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.2 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.29 per share a year ago.

06.08.2026

Cryoport Reports Second Quarter 2026 Financial Results

Second quarter revenue grew 8% year-over-year to $49.0 million Life Sciences Services revenue increased 15% year-over-year BioStorage/BioServices revenue grew 25% year-over-year Supporting 779 global clinical trials and 22 commercially approved cell and gene therapies (CGT) as of June 30, 2026 NASHVILLE, Tenn., Aug. 6, 2026 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, today announced financial results for its second quarter (Q2) and first half (H1) of 2026.

05.08.2026

Conestoga Micro Cap Composite Q2 2026 Leaders, Laggards, Buys And Sells

Revenue increased 19% year-over-year, reinforcing confidence that TWST's technology leadership and expanding product portfolio continue to drive market share gains. We continue to believe AORT's expanding aortic portfolio and product pipeline provide meaningful long-term growth opportunities. We remain encouraged by PLMR's disciplined underwriting approach, diversified specialty portfolio, and ability to historically deploy capital into attractive growth opportunities.

Cryoport, Inc. (CYRX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Cryoport, Inc. (CYRX)

CryoPort (CYRX) Upgraded to Buy: Here's Why

Cryoport, Inc. (CYRX) Q2 2026 Earnings Call Transcript

CryoPort Q2 Earnings Call Highlights

CryoPort, Inc. (CYRX) Reports Q2 Loss, Beats Revenue Estimates

Cryoport Reports Second Quarter 2026 Financial Results

Conestoga Micro Cap Composite Q2 2026 Leaders, Laggards, Buys And Sells

CryoPort (CYRX) Upgraded to Buy: Here's Why

Cryoport, Inc. (CYRX) Q2 2026 Earnings Call Transcript

CryoPort Q2 Earnings Call Highlights

CryoPort, Inc. (CYRX) Reports Q2 Loss, Beats Revenue Estimates

Cryoport Reports Second Quarter 2026 Financial Results

Conestoga Micro Cap Composite Q2 2026 Leaders, Laggards, Buys And Sells

Videolar

No Data

Press-relizlar

Cryoport Reports Second Quarter 2026 Financial Results

Search stocks

Cryoport, Inc. (CYRX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Cryoport, Inc. (CYRX)

CryoPort (CYRX) Upgraded to Buy: Here's Why

Cryoport, Inc. (CYRX) Q2 2026 Earnings Call Transcript

CryoPort Q2 Earnings Call Highlights

CryoPort, Inc. (CYRX) Reports Q2 Loss, Beats Revenue Estimates

Cryoport Reports Second Quarter 2026 Financial Results

Conestoga Micro Cap Composite Q2 2026 Leaders, Laggards, Buys And Sells

CryoPort (CYRX) Upgraded to Buy: Here's Why

Cryoport, Inc. (CYRX) Q2 2026 Earnings Call Transcript

CryoPort Q2 Earnings Call Highlights

CryoPort, Inc. (CYRX) Reports Q2 Loss, Beats Revenue Estimates

Cryoport Reports Second Quarter 2026 Financial Results

Conestoga Micro Cap Composite Q2 2026 Leaders, Laggards, Buys And Sells

Videolar

No Data

Press-relizlar

Cryoport Reports Second Quarter 2026 Financial Results